Welcome from
Matt Comyn, CEO Commonwealth Bank
Thank you for joining the 2023 Sohn Hearts & Minds Investment Leaders Conference. I’m delighted to welcome you to this opportunity to share exclusive insights and, importantly, raise money for Australian medical research.
Since the inception of the Sohn Hearts & Minds Investor Conference, the Commonwealth Bank has been a proud leading sponsor and we’re pleased to continue our support. Each year we see the significant influence and impact the conference has on medical research and the ability to build deeper relationships among the investment, scientific and philanthropic community.
This year’s theme ‘Think. Unthink. Rethink’ encourages us to challenge ourselves and our traditional ways of thinking and embrace new perspectives that could present great opportunities.
In today’s challenging economic environment, the conference’s philanthropic purpose is more important than ever, as we strive to better support our broader communities, where new approaches, considerations and advancements are critical.
To date, the Sohn Hearts & Minds Investment Leaders Conference has raised more than $50 million, and is already delivering better physical and mental health outcomes for many people, and helping build more resilient and sustainable communities.
On behalf of the Commonwealth Bank and Commonwealth Private, thank you for your commitment and support of the 2023 Sohn Hearts & Minds Investment Leaders Conference, and for helping us build a brighter future for all.
Matt Comyn
Chief Executive Officer
Commonwealth Bank
A heartfelt thank you
For being part of the eighth Sohn Hearts & Minds Conference, Australia’s premier investment leaders event.
Since 2016, Hearts & Minds has gathered respected local and global investment experts to share their valuable insights for Australian medical research. Every year we host the conference we are deeply humbled by the generosity of the investment community. All of you are eager to provide support and resources to ensure the conference is a success. Put simply, without your collective support, we wouldn’t be here.
Together, we are proud to announce that we have donated more than $60 million towards groundbreaking Australian medical research. With the ongoing success of the conference and our charitable listed investment company, Hearts and Minds Investments Limited (HM1), our beneficiaries can plan their future endeavours with greater financial certainty. This sense of security is vital when considering whether to embark on new and significant multi-year research projects.
We warmly welcome you to the Hearts & Minds Community of over 15,000 investors, and we hope you enjoy being involved. Once again, we express our deepest gratitude for your contribution.
Grounds AM
Co-Founder,
Hearts and Minds
Fowler
Co-Founder,
Hearts and Minds
Weiss AM
Co-Founder,
Hearts and Minds
Cuffe AO
Chairman,
HM1
Together we
have donated
to medical research
Hearts and Minds is dedicated to investing in Australian medical research through unconstrained funding.
We do this through an annual investor conference and a unique ASX-listed investment company, which has two objectives: to maximise long-term returns to shareholders and provide vital financial support to leading medical research institutes.
Discover how your contribution has advanced the health of Australians by visiting our impact insights.
.jpg)
.jpg)
